DRUG-INTERACTIONS BETWEEN PRESCRIBED AND OVER-THE-COUNTER MEDICATION

被引:29
作者
HONIG, PK [1 ]
GILLESPIE, BK [1 ]
机构
[1] GEORGETOWN UNIV,DEPT MED,WASHINGTON,DC 20007
关键词
D O I
10.2165/00002018-199513050-00003
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The use and availability of over-the-counter (OTC) medication is increasing. Although regulatory agencies take care to assure than nonprescription medications are safe and effective, these drugs still have the potential to have clinically significant interactions with prescription medicines, The major classes of OTC medication to be considered in this light include antacids, histamine H-2 receptor antagonists, NSAIDs, cough and cold preparations and the antiasthma products. Healthcare providers and patients/consumers should be educated regarding possible drug interactions, patient drug regimens should be simplified where possible, and all therapeutic failures and adverse reactions should be investigated with regard to the potential contribution of OTC drug products, Regulatory agencies and pharmaceutical manufacturers should ensure that nonprescription drug labelling is complete and intelligible to meet these objectives, Consideration should be given to improving the postmarketing surveillance of OTC medications.
引用
收藏
页码:296 / 303
页数:8
相关论文
共 73 条
[1]  
Newton G.D., Pray W.S., Popovich N.G., New OTCs: a selected review, Am Pharm, 34, (1994)
[2]  
Morgan P.P., Cohen L., Off the prescription pad and over the counter: the trend toward drug deregulation grows, Can Med Assoc J, 152, (1995)
[3]  
Mant A., Whicker S., Kwok Y.S., Over-the-counter self-medication, Drugs Aging, 2, (1992)
[4]  
Holt G.A., Hall E.L., The self-care movement, Handbook of nonprescription drugs, pp. 1-10, (1993)
[5]  
Gebhart F., Rx-to-OTC switches to be mixed bag for pharmacists in future, Drug Topics, 134, (1990)
[6]  
Cranz H., Over-the-counter drugs: the issues, Drug Saf, 1, (1990)
[7]  
Sorofman B., Drug promotion in self-care and self-medication, J Drug Issues, 22, (1992)
[8]  
Honig P.K., Cantilena L.R., Polypharmacy: pharmacokinetic perspectives, Clin Pharmacokinet, 26, pp. 85-90, (1994)
[9]  
Ostrom J.R., Hammarlund E.R., Christensen D.B., Et al., Medication usage in an elderly population, Med Care, 23, (1985)
[10]  
Stewart R.B., Yedinak K.C., Ware, Polypharmacy in psychiatry: three case studies and methods for prevention, DICP: Ann Pharmacother, 26, (1992)